Rang	Name	Position
1	Dr. Garo H. Armen Ph.D.	Founder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman
2	Dr. Steven J. O'Day M.D., Ph.D.	Chief Medical Officer
3	Dr. Jennifer S. Buell Ph.D.	Director and President & CEO of MiNK Therapeutics
4	Craig Winter	Chief Information Officer
5	Mr. Zack Armen	Vice President of Investor Relations & Corporate Development
6	Ms. Stefanie Perna-Nacar	Chief Communications & Government Relations Officer
7	Ms. Tracy Mazza Clemente	Chief People Officer
8	Dr. Todd Jude Yancey M.D.	Member of Advisory Board & Chief Strategic Advisor
9	Dr. Robin G. Taylor M.B.A., Ph.D.	Chief Commercial Officer
10	Dr. Kamel Djazouli M.D.	Head of Medical Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Capital Management, LLC	3,20%	10,00 Mio. USD
2	Vanguard Portfolio Management, LLC	2,65%	8,29 Mio. USD
3	Siren, L.L.C.	2,36%	7,39 Mio. USD
4	Marshall Wace Asset Management Ltd	1,53%	4,78 Mio. USD
5	BlackRock Inc	1,21%	3,79 Mio. USD
6	GlobeFlex Capital, L.P.	0,93%	2,91 Mio. USD
7	Geode Capital Management, LLC	0,77%	2,42 Mio. USD
8	Morgan Stanley - Brokerage Accounts	0,66%	2,05 Mio. USD
9	Renaissance Technologies Corp	0,63%	1,98 Mio. USD
10	Man Group PLC	0,62%	1,94 Mio. USD
11	UBS Group AG	0,52%	1,63 Mio. USD
12	Acadian Asset Management LLC	0,48%	1,49 Mio. USD
13	Vanguard Fiduciary Trust Co	0,45%	1,39 Mio. USD
14	Connor Clark & Lunn Inv Mgmt Ltd	0,44%	1,38 Mio. USD
15	Panagora Asset Management Inc	0,40%	1,25 Mio. USD
16	Jump Financial LLC	0,35%	1,09 Mio. USD
17	State Street Corp	0,35%	1,08 Mio. USD
18	Walleye Trading Advisors, LLC	0,27%	0,84 Mio. USD
19	Bank of America Corp	0,26%	0,82 Mio. USD
20	683 Capital Management LLC	0,25%	0,79 Mio. USD